본문 바로가기

Optimal blood pressure target in the elderly: rationale and design of the HOW to Optimize eLDerly systolic Blood Pressure (HOWOLD-BP) trial

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q2KCI Q3
저널
KOREAN JOURNAL OF INTERNAL MEDICINE37(5) · pp.1070 · 2022
피인용
Web of Science 5Scopus 6KCI 3
FWCI (Scopus)
0.56
JCR IF
JCR 2021 3.165
ISSN
1226-3303

저자

  1. Lee, Dong-Hwa제1저자Chungbuk Natl Univ, Dept Internal Med, Coll Med, 776 1sunhwan Ro, Cheongju 28644, South Korea
  2. Lee, Ju-HeeChungbuk Natl Univ, Dept Internal Med, Coll Med, 776 1sunhwan Ro, Cheongju 28644, South Korea
  3. Kim, So YoungChungbuk Natl Univ Hosp, Dept Cardiol & Cardiocerebrovasc Ctr, Cheongju, South Korea
  4. Lee, Hae-YoungSeoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
  5. Choi, Jung-YeonSeoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
  6. Hong, YoujinSeoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea
  7. Park, Sue K.Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea
  8. Ryu, Dong RyeolKangwon Natl Univ, Kangwon Natl Univ Hosp, Dept Internal Med, Div Cardiol,Sch Med, Chunchon, South Korea
  9. Yang, Dong HeonKyungpook Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea
  10. Hwang, Seok-JaeGyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Internal Med, Coll Med, Jinju, South Korea
  11. 최정현Pusan Natl Univ Hosp, Med Res Inst, Dept Internal Med, Div Cardiol, Busan, South Korea
  12. Kim, Kye HunChonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea
  13. Lee, Sun HwaJeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol,Med Sch, Jeonju, South Korea
  14. Joo, Seung JaeJeju Natl Univ Hosp, Dept Cardiol, Jeju, South Korea
  15. Park, Jae-HyeongChungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med, Daejeon, South Korea
  16. Kim, Sang-HyunSeoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
  17. Kim, Hack-LyongSeoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
  18. Kim, Kwang-IlSeoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
  19. Cho, Myeong-Chan교신저자Chungbuk Natl Univ, Dept Internal Med, Coll Med, 776 1sunhwan Ro, Cheongju 28644, South Korea

초록

Background/Aims: The optimal systolic blood pressure (SBP) goal for elderly patients with hypertension, especially to reduce cardiovascular disease (CVD) incidence and improve outcome, is unclear. This study aimed to evaluate the beneficial effects of intensive treatment for hypertension on the incidence of CVD in elderly Korean patients. Methods: The HOW to Optimize eLDerly systolic Blood Pressure (HOWOLD-BP) trial is a multicenter, parallel-design, open-label, randomized controlled trial designed to evaluate whether intensive treatment (SBP ??? 130 mmHg) will provide more benefits in lowering the incidence and mortality associated with CVD than standard treatment (SBP ??? 140 mmHg) in elderly patients with hypertension aged ??? 65 years. For this study, eleven university hospitals in Korea will enroll approximately 3,176 elderly patients with hypertension between 2019 and 2022. Patients will be requested to visit the clinic every 4 months for the first year and every 6 months thereafter for 36 months. Parameters, including clinic and home blood pressure, anthropometric and laboratory findings, and frailty assessments, will be collected according to the standardized protocol. The primary outcome is a composite of CVD (acute coronary syndrome, stroke, and heart failure) incidence and cardiovascular deaths. Results: As of December 2021, 1,655 participants had been enrolled in the study, including 831 patients in the standard group and 824 patients in the intensive group. Conclusions: The HOWOLD-BP trial is the first study performed in Korea to evaluate the beneficial effects of intensive blood pressure treatment on CVD in elderly patients with hypertension. The results of this study will help clarify the appropriate target SBP for this population.

키워드

Randomized controlled trialHypertensionBlood pressureGoalsAgedKOREAN VERSIONHYPERTENSIONOLDERVALIDATIONREDUCTIONMORBIDITYVALSARTANPLACEBOFEVER

식별자

Scopus EID
2-s2.0-85137746025
WoS UID
000829966800001
KCI
ART002868649